Supernus, Indivior get early termination of US waiting period
MLex Summary: Merging drugmakers Supernus Pharmaceuticals and Indivior Pharmaceuticals got early termination of the waiting period for their deal, according to a notice from the US Federal Trade Commission.Statement follows below:...To view the full article, register now.
Already a subscriber? Click here to view full article